MedPath

Alvogen Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

36

FDA:36

Drug Approvals

Melphalan

Approval Date
Mar 21, 2024
FDA

Buprenorphine and Naloxone

Approval Date
Jan 31, 2024
FDA

Hydrocodone Bitartrate

Approval Date
Dec 19, 2023
FDA

Dexamethasone

Approval Date
Nov 29, 2023
FDA

Carbidopa Tablets, 25 mg

Approval Date
Nov 14, 2023
FDA

Disulfiram

Approval Date
Nov 13, 2023
FDA

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII

Approval Date
Oct 31, 2023
FDA

lisdexamfetamine dimesylate

Approval Date
Oct 20, 2023
FDA

Fluocinonide Gel

Approval Date
Jul 18, 2023
FDA

Fluocinonide

Approval Date
Jul 18, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy